Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Tuberous Sclerosis 5Seizures 4Marijuana Abuse 3Colonic Neoplasms 3Breast Neoplasms 3Sturge-Weber Syndrome 2Nausea 2Lennox Gastaut Syndrome 2Glioblastoma 2Epilepsies, Myoclonic 2Anxiety Disorders 2Vomiting 1Tuberous Sclerosis 2 1Tuberous Sclerosis 1 1Spasms, Infantile 1Solid Tumor 1Rectal Neoplasms 1Prostatic Neoplasms 1Parasomnias 1Pancreatic Neoplasms 1Pain 1Neoplasms 1Multiple Myeloma 1Liver Neoplasms 1Liver Cirrhosis 1Gallbladder Neoplasms 1Epilepsy 1Dysgeusia 1Drug Resistant Epilepsy 1Colorectal Neoplasms 1

Interventions

Surveys and Questionnaires 3Testosterone 2Fatty Acids, Omega-3 2Exercise 2Educational Status 2Acupuncture Therapy 2methyl hydroxyethyl cellulose 1guizhi-shaoyao-zhimu decoction 1canakinumab 1Yoga 1Walking 1Vitamin B 12 1Therapeutics 1Occupational Therapy 1Letrozole 1Hyaluronic Acid 1Glucosamine 1Glucaric Acid 1Gabapentin 1Fish Oils 1Docosahexaenoic Acids 1Diphosphonates 1Diet Therapy 1Denosumab 1Curcumin 1Chondroitin Sulfates 1Chondroitin 1Cholecalciferol 1Cannabidiol 1Calcium Gluconate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Arthralgia × Cannabidiol × Clear all
NCT04754399 2025-05-09

Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias

University of Michigan Rogel Cancer Center

Phase 2 Completed
40 enrolled 10 charts
Breast

Breast Neoplasms, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡